Derma Sciences (DSCI) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts DSCI Hot Sheet
Price: $7.00 --0%
Financial Fact:
Research and development: 76.27K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 76.27K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.45), $0.02 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $20.2 million versus the consensus estimate of $21.9 million.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
